Koers MEDADVISO Australian S.E.
Aandelen
Geavanceerde medische apparatuur & technologie
Omzet 2024 * | 121 mln. 80,96 mln. 75,6 mln. | Omzet 2025 * | 144 mln. 95,89 mln. 89,54 mln. | Marktkapitalisatie | 275 mln. 183 mln. 171 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | - 0 0 | Nettowinst (verlies) 2025 * | 3 mln. 2 mln. 1,87 mln. | EV/omzet 2024 * | 2,19 x |
Nettoliquiditeiten 2024 * | 8,75 mln. 5,83 mln. 5,45 mln. | Nettoliquiditeiten 2025 * | 15,05 mln. 10,03 mln. 9,37 mln. | EV/omzet 2025 * | 1,81 x |
K/w-verhouding 2024 * |
746
x | K/w-verhouding 2025 * |
107
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 60,77% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Richard Ratliff
CEO | Chief Executive Officer | - | 15-07-22 |
Ancila Desai
DFI | Director of Finance/CFO | - | 17-10-22 |
Craig Schnuriger
CTO | Chief Tech/Sci/R&D Officer | - | 30-06-20 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Linda Jenkinson
CHM | Chairman | - | 28-02-22 |
Kevin Hutchinson
BRD | Director/Board Member | - | 23-11-22 |
Richard Ratliff
CEO | Chief Executive Officer | - | 15-07-22 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-4,78% | 29,93 mld. | |
+49,49% | 9,7 mld. | |
+34,36% | 4,42 mld. | |
-42,51% | 2,3 mld. | |
-8,48% | 1,52 mld. | |
-28,98% | 1,21 mld. | |
-42,92% | 967 mln. | |
+7,71% | 957 mln. | |
-47,18% | 746 mln. |